Recommended Statement for Over-the-Counter Aspirin-Containing Drug Products Labeled With Cardiovascular Related Imagery Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 7, 2017
April 15, 2020
166bb50b-f162-4cfe-a252-d41e3ec062b5
Related Documents
Nonprescription Sunscreen Drug Products – Safety and Effectiveness Data
Guidance DocumentNovember 22, 2016Center for Drug Evaluation and Research
Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions
Guidance DocumentJanuary 11, 2017Center for Drug Evaluation and Research
Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use —: Guidance for Industry
Guidance DocumentNovember 17, 2015Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox